Buy LTRN by Oct 8, 2026.

Lantern just launched ZetaOmics, the computational biology module of its withZeta.ai platform. Unlike a standard LLM chatbot, it’s designed as an autonomous “computational biologist” that can perform end-to-end multi-omics and bioinformatics analyses from natural language queries. The company says it integrates 14 specialized tools and more than 615,000 curated cancer samples, with an early-access rollout now underway. What’s interesting to me is that this wasn’t announced out of nowhere: - April: withZeta launched commercially. - May: ZetaOmics appeared on the …